This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
TORONTO - We caught up with Society of Nuclear Medicine and Molecular Imaging (SNMMI) President Helen Nadel, MD, to discuss developments over the last year and how recent advances have represented the equivalent of an “industrial revolution” in nuclear medicine. Nadel also describes the electric atmosphere at this year’s meeting, how something old may be new again, and assesses the growing momentum in theranostics and AI.
New research analyzes the effectiveness of AI-generated reports in simplifying radiologists’ imaging interpretations into more easily understandable language, as judged by nonphysicians.
“Also needed are institutional and societal efforts to address LCS capacity, including screening infrastructure investments and quality benchmarking," experts wrote in JAMA Internal Medicine.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
AGFA is partnering with Europe's Alliance Medical to implement its cloud-based solutions across all of the imaging provider’s 120 sites throughout the UK.
AGFA is partnering with Europe's Alliance Medical to implement its cloud-based solutions across all of the imaging provider’s 120 sites throughout the UK.
Mobile, Alabama-based Infirmary Health has more than 700 doctors on its medical staff including about 20 radiologists, providing imaging services at a dozen locations.
A new AI PET/CT tool can assess patient cancer risk, predict tumor response, and estimate survival, according to research findings delivered June 10 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Toronto. In his presentation, Kevin Leung, PhD, from Johns Hopkins University in Baltimore, MD, shared his team’s results, which demonstrated the AI approach’s ability to accurately detect six different cancer types on whole-body PET/CT scans.
TORONTO – Clinician-scientists can do much to advance nuclear medicine, but it will take passion and stamina to succeed, said Ora Israel MD, at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Israel, an emeritus professor of imaging at the Technion – Israel Institute of Technology’s B. Rappaport School of Medicine in Haifa, Israel, discussed the need for clinician-scientists in nuclear medicine during her Henry N.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
The Value Realization Pyramid is designed to help healthcare providers derive value from their technological investments by leveraging high-quality data. It emphasizes standardized data driving efficient workflows enterprise-wide. Executives are empowered to make data-driven decisions and can optimize operations and achieve strategic goals.
Gadolinium dose for MR imaging can be reduced by more than half the standard level and still effectively distinguish meningiomas from surrounding tissues, researchers have reported. A team led by Tshea Dowers, MD, of the University of Toronto in Canada found that a gadolinium dose reduction of 62% offered sufficient visual delineation of brain tumors from healthy tissue.
A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis, a condition referred to as the 'Alzheimer's disease of the heart.' As the first amyloid-specific and pan-amyloid binding radiotracer designed for planar and SPECT/CT imaging, 99mTc-p5+14 could play an important role in early detection and treatment of cardiac amyloidosis.
The prevalence of up-to-date lung cancer screening with low-dose CT (LDCT) remains low -- especially in U.S. states that tend to have higher mortality rates of the disease, American Cancer Society (ACS) researchers have reported. A team led by Priti Bandi, PhD, of the ACS in Atlanta, GA, found that overall, in 2022 only 18.1% of men and women eligible for lung cancer screening underwent it, despite a 2021 expansion of the pool of eligible individuals.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Abnormal blood flow in the aorta is linked to inflammation and breakdown of the vessel wall in conditions where the aorta is dilated. The findings can contribute to better diagnosis and open up new ways to assess the risk of serious and usually fatal complications, such as rupture of the aorta.
David M. Goldenberg, MD, has been awarded the Society of Nuclear Medicine and Molecular Imaging's (SNMMI) Benedict Cassen Prize. David M. Goldenberg, MD. SNMMI The award is given every two years by the society's Education and Research Foundation for Nuclear Medicine and Molecular Imaging in recognition of outstanding work leading to a major advance in nuclear medicine science.
milla1cf Mon, 06/10/2024 - 18:17 June 10, 2024 — Carolyn J. Anderson , PhD, a trailblazer in nuclear medicine, has been named the 2024 recipient of the Georg Charles de Hevesy Nuclear Pioneer Award. The award was announced by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its 2024 Annual Meeting, June 8-11 in Toronto. For over three decades, Anderson’s pioneering research has laid the foundation for the growth of radiometal-based agents for diagnostic imaging and targeted r
AI healthcare firm Avenda Health is touting results from a study showing the ability of AI to accurately identify cancer in oncology imaging and diagnostics. The findings were published June 11 in The Journal of Urology. The study demonstrated that AI-assisted cancer tracking with Unfold AI, Avenda Health’s cancer mapping technology, improved urologists' and radiologists' abilities to identify prostate cancer extent by 45 times.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
From Field Service Engineer (FSE) to Account Executive (AE), Jay Tolsma’s role has evolved over his 20-year career with Cassling, but what hasn’t changed is Jay’s dedication to the job and his colleagues.
Delphinus Medical Technologies , developer of SoftVue Breast Tomographic Ultrasound, has named Michael Emery as the company's chief financial officer (CFO). Emery has more than 30 years of experience in financial executive leadership in the pharmaceutical and medical device industries. He was previously CFO and chief operating officer (COO) at Tyber Medical.
milla1cf Mon, 06/10/2024 - 18:13 June 10, 2024 — Siemens Healthineers announces the Food and Drug Administration clearance of the Biograph Trinion, a high-performance, energy-efficient positron emission tomography/computed tomography ( PET/CT ) scanner with a wide range of clinical capabilities and a low lifetime operational cost. “With the Biograph Trinion, Siemens Healthineers is proud to offer customers a high-performance PET/CT scanner that delivers the precision and speed needed for clinic
GE HealthCare introduced the MINItrace Magni at the Society of Nuclear Medicine and Molecular Imaging annual meeting (SNMMI) annual meeting, a newly designed, small-footprint cyclotron for in-house production of commercial PET radiotracers. The boom in theranostics is driving greater demand for gallium-68-based and other PET tracers used to diagnose patients in oncology, cardiology, and neurology, yet the limitations of traditionally used generators have created serious challenges for clinicians
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
In an interview at the SNMMI 2024 conference, Oliver Sartor, M.D. discussed key findings from new award-winning research evaluating the potential of Pluvicto in treating patients with taxane-naïve metastatic castration-resistant prostate cancer (mCRPC).
Michael J. Evans, PhD, has been named the 2024 recipient of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He will be honored at the SNMMI's annual meeting in Toronto. Evans, a professor in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco, was recognized for his work in biomarker discovery and radiopharmaceutical development.
A study published in the Journal of Medical Radiation Sciences compared 270 dental X-rays, from people who were told to hold their tongues against the roof of their mouths throughout the procedure. Radiographers managed to take high-quality X-rays in 75% of cases where the patient used a sticky fruit strip as an adhesive-aid, compared to just 36% of cases where the patient's mouth was empty.
Julie Dawn Bolin has been elected 2024-2025 president of the Society of Nuclear Medicine and Molecular Imaging Technologist Section (SNMMI-TS). Julie Dawn Bolin. Image courtesy of SNMMI. Bolin is program director of nuclear medicine technology at GateWay Community College in Phoenix, AZ, and nuclear medicine technologist at Banner University Medical Center in Tucson.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
305 
Let's personalize your content